Figure 2From: Clinical course and outcomes of type-2 diabetic patients after treatment intensification for insufficient glycaemic control - results of the 2 year prospective DiaRegis follow-up Change in therapy during follow-up period. Upper graph: Combinations of OADs, insulin, and GLP-1 analogues; Lower graph: differences in treatment therapies.Back to article page